Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FADSS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,064
Award facts
- Contract value 100% obligated
- $61,063.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $61,063.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on January 7, 2026. Dupixent (dupilumab) is a biologic immunosuppressant used to treat moderate-to-severe eczema, asthma, and other inflammatory conditions. The delivery order carries an ultimate completion date of January 8, 2026 and represents a non-competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company being Cencora, Inc., which operates under the AmerisourceBergen brand name.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This comprehensive IDC serves as the primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including medications across multiple therapeutic domains, vaccines, and specialty medical commodities. The DLA Medical Supply Chain utilizes this contract vehicle to efficiently meet the pharmaceutical procurement needs of military treatment facilities, the Defense Health Agency, the U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FADSS?
SPE2DR26FADSS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FADSS worth?
The government has obligated $61,064 on SPE2DR26FADSS.
Is contract SPE2DR26FADSS an order under another contract?
Yes. SPE2DR26FADSS is a delivery order under SPE2DR25D2011, an indefinite delivery contract.
Was contract SPE2DR26FADSS competed?
The extent of competition for SPE2DR26FADSS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award